Related Experiment Video

Updated: Jul 15, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

The effect of weight loss on the mean platelet volume in obese patients

Erkan Coban1, Alparslan Yilmaz, Ramazan Sari

  • 1Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey. ecoban@akdeniz.edu.tr

Platelets
|May 15, 2007
PubMed

Insights

Weight loss in obese women significantly reduced mean platelet volume (MPV), a marker of platelet activation. This suggests weight loss has anti-platelet effects, contributing to its benefits against cardiovascular disease and atherosclerosis.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Obesity is a chronic metabolic disorder linked to cardiovascular disease and atherosclerosis.
  • Platelet activation is crucial in cardiovascular disease pathophysiology.
  • Mean platelet volume (MPV) is an emerging risk marker for atherothrombosis.

Purpose of the Study:

  • To investigate the impact of weight loss on MPV in obese women.
  • To assess if weight loss influences platelet activation markers.

Main Methods:

  • A study involving 30 obese women and 30 non-obese controls.
  • Obese participants underwent a 3-month diet intervention.
  • Measurements included Body Mass Index (BMI), metabolic parameters, and MPV at baseline and after intervention.

Main Results:

  • Obese women had higher baseline MPV compared to controls (p=0.004).
  • MPV positively correlated with BMI in obese individuals (r=0.43, p=0.017).
  • Weight loss reduced BMI (p<0.001) and MPV (p=0.013) in obese women, with a positive correlation between weight loss and MPV reduction (r=0.41, p=0.024).

Conclusions:

  • Weight loss in obese women is associated with a significant reduction in MPV.
  • Weight loss may exert anti-platelet activation effects.
  • These anti-platelet properties may contribute to the antiatherogenic benefits of weight loss in obese patients.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...